Roger R. Beerli
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia.
Journal: Blood advances
Published: August 26, 2020
Partially shielded enzymes capable of processing large protein substrates.
Journal: Chemical communications (Cambridge, England)
Published: April 09, 2020
Sortase A Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody-Drug Conjugates.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 05, 2019
Characterization of the housekeeping sortase from the human pathogen Propionibacterium acnes: first investigation of a class F sortase.
Journal: The Biochemical journal
Published: November 15, 2018
A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer.
Journal: Journal for immunotherapy of cancer
Published: August 16, 2018
Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells.
Journal: Frontiers in immunology
Published: July 22, 2018
Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility.
Journal: Journal of molecular biology
Published: May 13, 2017
Cystatin F is a biomarker of prion pathogenesis in mice.
Journal: PloS one
Published: December 11, 2016
Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.
Journal: PloS one
Published: December 11, 2016
Highly Potent, Anthracycline-based Antibody-Drug Conjugates Generated by Enzymatic, Site-specific Conjugation.
Journal: Molecular cancer therapeutics
Published: October 14, 2016
Last Updated: 09/26/2026